MMM and Oracle webcast

Applying Technologies Across the End-to-End PV Process to Increase Compliance and Quality

29 Oct 2015
Andrew Rut, Chief Executive Officer, MyMeds&Me
Michael Braun-Boghos, Director of Safety Analytics, Oracle Health Sciences

Safe Harbor Statement

The following is intended to outline MyMeds&Me and Oracle Health Sciences  general product direction. It is intended for information purposes only, and may not be incorporated into any contract. It is not a commitment to deliver any material, code, or functionality, and should not be relied upon in making purchasing decisions. The development, release, and timing of any features or functionality described for Oracle’s products remains at the sole discretion of Oracle.

Agenda

  1. Industry Dynamics
  • What does the evolving PV landscape look like? What are the challenges we face?
  • Quality: what form does it take and how does it change across product portfolios?
  • Breaking down the PV business processes

2. Applying Technologies for Better Compliance and Quality

  • Use industry standards
  • Maximize the quality of case data intake
  • Automate the case processing steps
  • Track operational metrics
  • In aggregate reporting, separate the logic layer from the presentation layer
  • Standardize the signal review and surveillance process

Download Webcast

MyMeds&Me are sponsoring our upcoming World Drug Safety Americas Congress, taking place on the 20-21 of April in Chicago. Join us in 2016 to get an opportunity to engage and sit alongside the pioneers who are driving forward innovation in pharmacovigilance.

Leave a Reply

Your email address will not be published. Required fields are marked *